Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
77 - Can we use American guidelines to complement or supplement Canadian guidelines in promotional pieces? Often guidelines may have slightly different recommendations or one maybe published later than the other.
-
You can generally use valid, published American guidelines to add further support to statements from the published Canadian guidelines. In such cases, the spirit should be to show that the consensus sources are in agreement. We also often permit American guidelines when there are no Canadian guidelines for that specific therapeutic area. We do not, however, consider American guidelines when they are inconsistent with the Canadian consensus. Statements taken from guidelines and used in advertising must be based on good evidence and consistent with the Terms of Market Authorization (s3.1). The PAAB encourages companies to distribute the complete published guideline and it should be the most recent available.
